PepGen Aktie News

BOSTON--(BUSINESS WIRE)---- $PEPG #DM1--PepGen veröffentlicht Finanzergebnisse für das zweite Quartal 2026 und aktuelle Unternehmenshighlights.

BOSTON--(BUSINESS WIRE)---- $PEPG #DM1--PepGen bringt PGN-EDODM1 nach DSMB-Review in die höchste Dosis-Kohorte der Phase‑2‑Studie FREEDOM2‑DM1 voran.

BOSTON--(BUSINESS WIRE)--PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases, today announced that data from its PGN-EDODM1 program will be presented in a poster and late-breaking oral presentation at the 15th International Myoto...

BOSTON--(BUSINESS WIRE)--PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases, today reported financial results and recent corporate highlights for the quarter ended March 31, 2026, and recent corporate highlights. "We made encour...